Belarusian pharmaceutical enterprises intend to implement over 20 investment projects by 2030. Sergei Kazakevich, Director General of the managing company of the holding company Belpharmprom, made the statement during the roundtable session held in BelTA’s press center to discuss the development of the national pharmaceutical industry. A strategy has already been drafted to guide the manufacturing of staple pharmaceutical products and preparations for the next decade. In 2021-2030 Belpharmprom enterprises intend to implement 23 investment projects. About 300 medications will be developed within the next five years. According to the executive, the government has always paid close attention to the development of the pharmaceutical industry. As many as 37 major investment projects worth a total of about $345 million have been implemented in the Belarusian pharmaceutical industry since 2012. A number of projects are being implemented.